Title |
Eastern India Collaboration on Multisystem Inflammatory Syndrome in Children (EICOMISC): A Multicenter Observational Study of 134 Cases
|
---|---|
Published in |
Frontiers in Pediatrics, March 2022
|
DOI | 10.3389/fped.2022.834039 |
Pubmed ID | |
Authors |
Snehamayee Nayak, Prakash Chandra Panda, Basudev Biswal, Sunil Kumar Agarwalla, Amit Kumar Satapathy, Pradeep Kumar Jena, Krishna Mohan Gulla, Debasmita Rath, Anuspandana Mahapatra, Pravakar Mishra, Debashree Priyadarshini, Samarendra Mahapatro, Saurav Nayak, Rashmi Ranjan Das, EICOMISC Study Group, Majhi Subash Chandra Kumar, Meher Sitanshu, Poddar Chandrakant, Sahoo Jyotiprakash, Mohanty Martina, Padhy Satya Brata, Nayak Bijan Kumar, Dash Shovendra Kumar, Meher Soumya Ranjan, Panigrahi Pranab Kumar, Srikanth |
Abstract |
Few single center studies from resource-poor settings have reported about the epidemiology, clinical feature and outcome of multisystem inflammatory syndrome in children (MIS-C). However, larger data from multi-center studies on the same is lacking including from Indian setting. This retrospective collaborative study constituted of data collected on MIS-C from five tertiary care teaching hospitals from Eastern India. Children ≤ 15 years of age with MIS-C as per the WHO criteria were included. Primary outcome was mortality. A total of 134 MIS-C cases were included (median age, 84 months; males constituted 66.7%). Fever was a universal finding. Rash was present in 40%, and conjunctivitis in 71% cases. Gastro-intestinal and respiratory symptoms were observed in 50.7% and 39.6% cases, respectively. Co-morbidity was present in 23.9% cases. Shock at admission was noted in 35%, and 27.38% required mechanical ventilation. Fifteen (11.2%) children died. The coronary abnormalities got normalized during follow-up in all except in one child. Initial choice of immunomodulation had no effect on the outcomes. Presence of underlying co-morbidity, lymphopenia, thrombocytosis, hyponatremia, increased LDH (>300 U/L), and hypoalbuminemia were the factors significantly associated an increased mortality. MIS-C has myriad of manifestations. Underlying co-morbidity, lymphopenia, thrombocytosis, hyponatremia, increased LDH (>300 U/L), and hypoalbuminemia were associated with an increased mortality. No difference in outcome was noted with either steroid or IVIg or both. Coronary artery abnormalities resolved in nearly all cases. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 20% |
India | 1 | 10% |
Sri Lanka | 1 | 10% |
Israel | 1 | 10% |
Unknown | 5 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 70% |
Scientists | 2 | 20% |
Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 10% |
Other | 2 | 7% |
Student > Bachelor | 2 | 7% |
Researcher | 2 | 7% |
Lecturer | 1 | 3% |
Other | 4 | 14% |
Unknown | 15 | 52% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 14% |
Environmental Science | 3 | 10% |
Chemical Engineering | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 2 | 7% |
Unknown | 17 | 59% |